XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.

Vanhove B, Marot S, So RT, Gaborit B, Evanno G, Malet I, Lafrogne G, Mevel E, Ciron C, Royer PJ, Lheriteau E, Raffi F, Bruzzone R, Mok CKP, Duvaux O, Marcelin AG, Calvez V

Open source

DOI
10.3389/fimmu.2021.761250
Published
2021
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2021.761250,
  title = {XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.},
  author = {Vanhove B and Marot S and So RT and Gaborit B and Evanno G and Malet I and Lafrogne G and Mevel E and Ciron C and Royer PJ and Lheriteau E and Raffi F and Bruzzone R and Mok CKP and Duvaux O and Marcelin AG and Calvez V},
  year = {2021},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2021.761250},
  url = {https://doi.org/10.3389/fimmu.2021.761250}
}

RIS

TY  - JOUR
TI  - XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
AU  - Vanhove B
AU  - Marot S
AU  - So RT
AU  - Gaborit B
AU  - Evanno G
AU  - Malet I
AU  - Lafrogne G
AU  - Mevel E
AU  - Ciron C
AU  - Royer PJ
AU  - Lheriteau E
AU  - Raffi F
AU  - Bruzzone R
AU  - Mok CKP
AU  - Duvaux O
AU  - Marcelin AG
AU  - Calvez V
PY  - 2021
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2021.761250
UR  - https://doi.org/10.3389/fimmu.2021.761250
ER  - 

APA

B, V., S, M., RT, S., B, G., G, E., I, M., G, L., E, M., C, C., PJ, R., E, L., F, R., R, B., CKP, M., O, D., AG, M., & V, C. (2021). XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2021.761250

Source records